Customization: | Available |
---|---|
Customized: | Customized |
Certification: | ISO, CE |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Portable LCD Arm Ischemic Disease Training Instrument
The ischemic disease training instrument consists of a main machine, an inflatable trachea and a cuff. When the training instrument works, the air pressure generated by the main machine exerts periodic pressure on the upper limbs of human body through the cuff, so as to artificially control the time of blood vessel occlusion and opening, enhance the ischemic tolerance of tissues and organs, and assist in improving the ischemic preconditioning ability of remote organs through intermittent ischemic training of the upper arms.
Product Name | Portable LCD Arm Ischemic Disease Training Instrument |
Pressure | 160mmHg-200mmHg |
Display | LCD Digital Display |
Type | Arm Type |
Function | Ischemic disease checking |
Power Source | Electricity |
Material | Plastic |
Treatment Frequency | 50Hz±1Hz |
Environmental temperature range | 5ºC~40ºC |
Power | AC 220V±22V |
Applicable for:
Arm Ischemic Disease Training Instrument:
Hypertension,Cardiovascular and cerebrovascular patients,Cerebral apoplexy,Atherosclerosis,Chest tightness and shortness of breath,
Coronary heart disease,Peripheral artery stenosis, Dizziness, headache
Contraindications:
1.Serious diseases of brain, lung, kidney and other organs are not controlled and stable
2.Uncontrolled infection and unexplained fever
3.Coagulation dysfunction or active visceral bleeding
4.Malignant tumor patients
5.Infants and pregnant women
6.Patients with peripheral vascular diseases
7.Patients with severe primary hypertension whose blood pressure is not controlled within the normal range
8.Vasculitis, Raynaud's disease, diabetic foot/hand, capillary fragility, multiple peripheral neuropathy, etc
9.Severe limb necrosis and infection
10.Patients with venous thrombosis and suspected venous thrombosis
11.Patients with acute inflammation, suppuration, skin damage and hematoma are treated
12.Patients with severe dermatosis at the treatment site
13.Patients with cardiopulmonary insufficiency, especially heart failure
14.Patients whose fractures are not fixed or treated with external fixation